{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:53:13Z","timestamp":1767905593799,"version":"3.49.0"},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. pediatr. gastroenterol. nutr."],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background and Aim:<\/jats:title><jats:p>Budesonide (BUD) is being used in pediatric Crohn disease (CD) because it is believed to have the potential to reduce corticosteroid\u2010related toxicity; however, few data are available describing its use. The aim of the present study was to describe BUD use in an inception cohort of pediatric patients with CD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Data were derived from the prospective Pediatric IBD Collaborative Research Group Registry established in 2002 in North America. Use of BUD in children with CD was examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>BUD was used in 119 of 932 (13%) of children with newly diagnosed CD, with 56 of 119 (47%) starting BUD \u226430 days of diagnosis (26\/56 with ileum and\/or ascending colon [IAC] disease). BUD was used as monotherapy (9%), in combination with 5\u2010aminosalicylates (77%), or in combination with immunomodulators (43%). Forty\u2010three percent (24\/56) went on to receive conventional corticosteroid at some point following their first BUD course. For the 63 of 119 (53%) who started BUD beyond the diagnosis period, 51 of 63 (81%) also received prednisone, with BUD used as a means of weaning from prednisone in 17 of 63 (27%). Patients with IAC disease who received BUD \u226430 days of diagnosis were just as likely to have received conventional corticosteroids by 1 year as were those who did not receive BUD \u226430 days of diagnosis. Two\u2010thirds (77\/119) of patients received BUD for \u22646 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>BUD is being used among pediatric patients newly diagnosed as having CD, although the majority does not have disease limited to the IAC. BUD monotherapy was rare, and further data are required to better define the role of BUD in the treatment of pediatric CD.<\/jats:p><\/jats:sec>","DOI":"10.1097\/mpg.0b013e31824a09c2","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T05:05:51Z","timestamp":1326863151000},"page":"200-204","source":"Crossref","is-referenced-by-count":10,"title":["Budesonide Use in Pediatric Crohn Disease"],"prefix":"10.1002","volume":"55","author":[{"given":"Anthony","family":"Otley","sequence":"first","affiliation":[{"name":"Division of Pediatric Gastroenterology IWK Health Centre Halifax Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"LeLeiko","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Hasbro Children's Hospital Providence RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Langton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Connecticut Children's Medical Center Hartford CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trudy","family":"Lerer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Connecticut Children's Medical Center Hartford CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mack","sequence":"additional","affiliation":[{"name":"Children's Hospital of Eastern Ontario Ottawa Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Evans","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Nutrition Nemours Children's Clinic Jacksonville FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Pfefferkorn","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology Riley Hospital for Children Indianapolis IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology Nationwide Children's Hospital Columbus OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Rosh","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology Goryeb Children's Hospital\/Atlantic Health Morristown NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology Hospital for Sick Children Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Oliva\u2010Hemker","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology Johns Hopkins Hospital Baltimore MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha","family":"Kay","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology Cleveland Clinic Cleveland OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athos","family":"Bousvaros","sequence":"additional","affiliation":[{"name":"Children's Hospital Boston MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Stephens","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Division of Pediatric Gastroenterology, Hepatology, and Nutrition Medical College of Wisconsin Milwaukee WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Samson","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology Cincinnati Children's Hospital Medical Center Cincinnati OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Grossman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition Children's Hospital of Philadelphia Philadelphia PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Keljo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Division of Pediatric Gastroenterology Children's Hospital of Pittsburgh Pittsburgh PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Markowitz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Division of Pediatric Gastroenterology Cohen Children's Hospital New Hyde Park NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Hyams","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Connecticut Children's Medical Center Hartford CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Pediatric IBD Collaborative Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425250903124355"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1536-4801.2003.tb07999.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199550050-00006"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528708991947"},{"key":"e_1_2_8_6_1","first-page":"161","article-title":"Lipophilicity and receptor affinity of gulcocorticoids","volume":"137","author":"Wurthwein G","year":"1992","journal-title":"Pharm Z Wiss"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00141.x"},{"key":"e_1_2_8_8_1","unstructured":"SeowCH BenchimolEI GriffithsAM et al. Budesonide for induction of remission in Crohn's disease.Cochrane Database Syst Rev2008:CD000296."},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","unstructured":"OtleyA SteinhartAH. Budesonide for induction of remission in Crohn's disease.Cochrane Database Syst Rev2005:CD000296.","DOI":"10.1002\/14651858.CD000296.pub2"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00867.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.168"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200401000-00008"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.119992"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1536-4801.2001.tb07405.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20881"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01386.x"},{"key":"e_1_2_8_17_1","unstructured":"BenchimolEI SeowCH OtleyAR et al. Budesonide for maintenance of remission in Crohn's disease.Cochrane Database Syst Rev2009:CD002913."},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70254-9"},{"key":"e_1_2_8_19_1","first-page":"247","article-title":"Treatment of active Crohn's ileocolitis with oral pH\u2010modified budesonide","volume":"33","author":"Caesar I","year":"1995","journal-title":"Z Gastroenterol"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.2.209"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409293311303"},{"key":"e_1_2_8_22_1","first-page":"905","article-title":"Oral pH\u2010modified release budesonide versus 6\u2010methylprednisolone in active Crohn's disease","volume":"8","author":"Gross V","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05835.x"}],"container-title":["Journal of Pediatric Gastroenterology and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/MPG.0b013e31824a09c2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T08:26:01Z","timestamp":1705566361000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/MPG.0b013e31824a09c2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1097\/MPG.0b013e31824a09c2"],"URL":"https:\/\/doi.org\/10.1097\/mpg.0b013e31824a09c2","archive":["Portico"],"relation":{},"ISSN":["0277-2116","1536-4801"],"issn-type":[{"value":"0277-2116","type":"print"},{"value":"1536-4801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}